Norges Bank’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $19.8M | Buy |
+406,487
| New | +$19.8M | ﹤0.01% | 1190 |
|
2025
Q1 | – | Sell |
-443,536
| Closed | -$17.5M | – | 405 |
|
2024
Q4 | $17.5M | Buy |
+443,536
| New | +$17.5M | ﹤0.01% | 1254 |
|
2024
Q3 | – | Sell |
-650,208
| Closed | -$35.1M | – | 412 |
|
2024
Q2 | $35.1M | Buy |
650,208
+59,940
| +10% | +$3.24M | 0.01% | 1050 |
|
2024
Q1 | $40.2M | Sell |
590,268
-27,318
| -4% | -$1.86M | 0.01% | 1041 |
|
2023
Q4 | $38.7M | Buy |
617,586
+31,286
| +5% | +$1.96M | 0.01% | 1024 |
|
2023
Q3 | $26.6M | Buy |
586,300
+9,267
| +2% | +$421K | 0.01% | 1113 |
|
2023
Q2 | $32.4M | Sell |
577,033
-52,619
| -8% | -$2.95M | 0.01% | 1058 |
|
2023
Q1 | $28.5M | Sell |
629,652
-85,776
| -12% | -$3.88M | 0.01% | 1099 |
|
2022
Q4 | $29.1M | Buy |
715,428
+48,660
| +7% | +$1.98M | 0.01% | 1096 |
|
2022
Q3 | $43.6M | Buy |
666,768
+76,191
| +13% | +$4.98M | 0.01% | 829 |
|
2022
Q2 | $35.9M | Sell |
590,577
-23,256
| -4% | -$1.41M | 0.01% | 940 |
|
2022
Q1 | $38.5M | Buy |
613,833
+21,096
| +4% | +$1.32M | 0.01% | 1025 |
|
2021
Q4 | $44.9M | Sell |
592,737
-72,870
| -11% | -$5.52M | 0.01% | 1007 |
|
2021
Q3 | $74.5M | Buy |
665,607
+41,517
| +7% | +$4.65M | 0.02% | 742 |
|
2021
Q2 | $101M | Buy |
624,090
+67,829
| +12% | +$11M | 0.02% | 640 |
|
2021
Q1 | $67.8M | Sell |
556,261
-6,830
| -1% | -$832K | 0.02% | 798 |
|
2020
Q4 | $86.2M | Sell |
563,091
-9,296
| -2% | -$1.42M | 0.02% | 656 |
|
2020
Q3 | $47.9M | Buy |
572,387
+73,909
| +15% | +$6.18M | 0.01% | 860 |
|
2020
Q2 | $36.6M | Buy |
498,478
+335,761
| +206% | +$24.7M | 0.01% | 1050 |
|
2020
Q1 | $6.9M | Buy |
162,717
+142,557
| +707% | +$6.05M | ﹤0.01% | 1742 |
|
2019
Q4 | $1.23M | Hold |
20,160
| – | – | ﹤0.01% | 2010 |
|
2019
Q3 | $826K | Buy |
+20,160
| New | +$826K | ﹤0.01% | 2043 |
|